Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 235

1.

Surgical and molecular characterization of primary and metastatic disease in a neuroendocrine tumor arising in a tailgut cyst.

Erdrich J, Schaberg K, Khodadoust MS, Zhou L, Shelton AA, Visser BC, Ford JM, Alizadeh AA, Quake SR, Kunz PL, Beausang JF.

Cold Spring Harb Mol Case Stud. 2018 Aug 7. pii: mcs.a003004. doi: 10.1101/mcs.a003004. [Epub ahead of print]

2.

Contrast-Enhanced Ultrasound Determines Supraspinatus Muscle Atrophy After Cuff Repair and Correlates to Functional Shoulder Outcome.

Fischer C, Gross S, Zeifang F, Schmidmaier G, Weber MA, Kunz P.

Am J Sports Med. 2018 Aug 6:363546518787266. doi: 10.1177/0363546518787266. [Epub ahead of print]

PMID:
30080421
3.

Long-Term Survivors of Pancreatic Cancer: A California Population-Based Study.

Kardosh A, Lichtensztajn DY, Gubens MA, Kunz PL, Fisher GA, Clarke CA.

Pancreas. 2018 Sep;47(8):958-966. doi: 10.1097/MPA.0000000000001133.

PMID:
30074526
4.

Precision Measurement of the First Ionization Potential of Nobelium.

Chhetri P, Ackermann D, Backe H, Block M, Cheal B, Droese C, Düllmann CE, Even J, Ferrer R, Giacoppo F, Götz S, Heßberger FP, Huyse M, Kaleja O, Khuyagbaatar J, Kunz P, Laatiaoui M, Lautenschläger F, Lauth W, Lecesne N, Lens L, Minaya Ramirez E, Mistry AK, Raeder S, Van Duppen P, Walther T, Yakushev A, Zhang Z.

Phys Rev Lett. 2018 Jun 29;120(26):263003. doi: 10.1103/PhysRevLett.120.263003.

PMID:
30004781
5.

Probing Sizes and Shapes of Nobelium Isotopes by Laser Spectroscopy.

Raeder S, Ackermann D, Backe H, Beerwerth R, Berengut JC, Block M, Borschevsky A, Cheal B, Chhetri P, Düllmann CE, Dzuba VA, Eliav E, Even J, Ferrer R, Flambaum VV, Fritzsche S, Giacoppo F, Götz S, Heßberger FP, Huyse M, Kaldor U, Kaleja O, Khuyagbaatar J, Kunz P, Laatiaoui M, Lautenschläger F, Lauth W, Mistry AK, Minaya Ramirez E, Nazarewicz W, Porsev SG, Safronova MS, Safronova UI, Schuetrumpf B, Van Duppen P, Walther T, Wraith C, Yakushev A.

Phys Rev Lett. 2018 Jun 8;120(23):232503. doi: 10.1103/PhysRevLett.120.232503.

PMID:
29932712
6.

NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018.

Shah MH, Goldner WS, Halfdanarson TR, Bergsland E, Berlin JD, Halperin D, Chan J, Kulke MH, Benson AB 3rd, Blaszkowsky LS, Eads J, Engstrom PF, Fanta P, Giordano T, He J, Heslin MJ, Kalemkerian GP, Kandeel F, Khan SA, Kidwai WZ, Kunz PL, Kuvshinoff BW 2nd, Lieu C, Pillarisetty VG, Saltz L, Sosa JA, Strosberg JR, Sussman CA, Trikalinos NA, Uboha NA, Whisenant J, Wong T, Yao JC, Burns JL, Ogba N, Zuccarino-Catania G.

J Natl Compr Canc Netw. 2018 Jun;16(6):693-702. doi: 10.6004/jnccn.2018.0056.

PMID:
29891520
7.

Health-Related Quality of Life in Patients With Progressive Midgut Neuroendocrine Tumors Treated With 177Lu-Dotatate in the Phase III NETTER-1 Trial.

Strosberg J, Wolin E, Chasen B, Kulke M, Bushnell D, Caplin M, Baum RP, Kunz P, Hobday T, Hendifar A, Oberg K, Sierra ML, Thevenet T, Margalet I, Ruszniewski P, Krenning E; NETTER-1 Study Group.

J Clin Oncol. 2018 Jun 7:JCO2018785865. doi: 10.1200/JCO.2018.78.5865. [Epub ahead of print]

PMID:
29878866
8.

The structural basis of nanobody unfolding reversibility and thermoresistance.

Kunz P, Zinner K, Mücke N, Bartoschik T, Muyldermans S, Hoheisel JD.

Sci Rep. 2018 May 21;8(1):7934. doi: 10.1038/s41598-018-26338-z.

9.

Changes in Weight Associated With Telotristat Ethyl in the Treatment of Carcinoid Syndrome.

Weickert MO, Kaltsas G, Hörsch D, Lapuerta P, Pavel M, Valle JW, Caplin ME, Bergsland E, Kunz PL, Anthony LB, Grande E, Öberg K, Welin S, Lombard-Bohas C, Ramage JK, Kittur A, Yang QM, Kulke MH.

Clin Ther. 2018 Jun;40(6):952-962.e2. doi: 10.1016/j.clinthera.2018.04.006. Epub 2018 May 1.

10.

The Power of Trust.

Mou E, Schapira L, Kunz P.

JAMA Oncol. 2018 Apr 26. doi: 10.1001/jamaoncol.2018.0495. [Epub ahead of print] No abstract available.

PMID:
29710067
11.

Dual-frequency irradiation CEST-MRI of endogenous bulk mobile proteins.

Goerke S, Breitling J, Zaiss M, Windschuh J, Kunz P, Schuenke P, Paech D, Longo DL, Klika KD, Ladd ME, Bachert P.

NMR Biomed. 2018 Jun;31(6):e3920. doi: 10.1002/nbm.3920. Epub 2018 Apr 19.

PMID:
29672976
12.

Evaluation of 209At as a theranostic isotope for 209At-radiopharmaceutical development using high-energy SPECT.

Crawford JR, Robertson AKH, Yang H, Rodríguez-Rodríguez C, Esquinas PL, Kunz P, Blinder S, Sossi V, Schaffer P, Ruth TJ.

Phys Med Biol. 2018 Feb 21;63(4):045025. doi: 10.1088/1361-6560/aaaa95.

PMID:
29466250
13.

Evaluation of <sup>209</sup>At as a theranostic isotope for <sup>211</sup>At-radiopharmaceutical development using high-energy SPECT.

Crawford JR, Robertson AKH, Yang H, Rodriguez-Rodriguez C, Esquinas PL, Kunz P, Blinder S, Sossi V, Schaffer P, Ruth TJ.

Phys Med Biol. 2018 Jan 25. doi: 10.1088/1361-6560/aaaa95. [Epub ahead of print]

PMID:
29369043
14.

Telotristat ethyl in carcinoid syndrome: safety and efficacy in the TELECAST phase 3 trial.

Pavel M, Gross DJ, Benavent M, Perros P, Srirajaskanthan R, Warner RRP, Kulke MH, Anthony LB, Kunz PL, Hörsch D, Weickert MO, Lapuerta P, Jiang W, Kassler-Taub K, Wason S, Fleming R, Fleming D, Garcia-Carbonero R.

Endocr Relat Cancer. 2018 Mar;25(3):309-322. doi: 10.1530/ERC-17-0455. Epub 2018 Jan 12.

15.

Understanding the Patient Experience with Carcinoid Syndrome: Exit Interviews from a Randomized, Placebo-controlled Study of Telotristat Ethyl.

Anthony L, Ervin C, Lapuerta P, Kulke MH, Kunz P, Bergsland E, Hörsch D, Metz DC, Pasieka J, Pavlakis N, Pavel M, Caplin M, Öberg K, Ramage J, Evans E, Yang QM, Jackson S, Arnold K, Law L, DiBenedetti DB.

Clin Ther. 2017 Nov;39(11):2158-2168. doi: 10.1016/j.clinthera.2017.09.013. Epub 2017 Oct 23.

16.

Carcinoid Syndrome Complicating a Pancreatic Neuroendocrine Tumor: A Case Report.

Gerson JN, Witteles RM, Chang DT, Beygui RE, Iagaru AH, Kunz PL.

Pancreas. 2017 Nov/Dec;46(10):1381-1385. doi: 10.1097/MPA.0000000000000932.

PMID:
29040196
17.

Appropriate Use Criteria for Somatostatin Receptor PET Imaging in Neuroendocrine Tumors.

Hope TA, Bergsland EK, Bozkurt MF, Graham M, Heaney AP, Herrmann K, Howe JR, Kulke MH, Kunz PL, Mailman J, May L, Metz DC, Millo C, O'Dorisio S, Reidy-Lagunes DL, Soulen MC, Strosberg JR.

J Nucl Med. 2018 Jan;59(1):66-74. doi: 10.2967/jnumed.117.202275. Epub 2017 Oct 12. No abstract available.

PMID:
29025982
18.

Prevalence of gastrointestinal symptoms in Angelman syndrome.

Glassman LW, Grocott OR, Kunz PA, Larson AM, Zella G, Ganguli K, Thibert RL.

Am J Med Genet A. 2017 Oct;173(10):2703-2709. doi: 10.1002/ajmg.a.38401. Epub 2017 Aug 16.

PMID:
28816003
19.

Twists in nonlinear magneto-optic rotation with cold atoms.

Kunz PD, Meyer DH, Fatemi FK.

Opt Express. 2017 Jul 10;25(14):16392-16399. doi: 10.1364/OE.25.016392.

PMID:
28789143
20.

Biologics in gastrointestinal and pancreatic neuroendocrine tumors.

Liu IH, Kunz PL.

J Gastrointest Oncol. 2017 Jun;8(3):457-465. doi: 10.21037/jgo.2016.12.09. Review.

21.

Exploiting sequence and stability information for directing nanobody stability engineering.

Kunz P, Flock T, Soler N, Zaiss M, Vincke C, Sterckx Y, Kastelic D, Muyldermans S, Hoheisel JD.

Biochim Biophys Acta. 2017 Sep;1861(9):2196-2205. doi: 10.1016/j.bbagen.2017.06.014. Epub 2017 Jun 20.

22.

The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Midgut Neuroendocrine Tumors.

Strosberg JR, Halfdanarson TR, Bellizzi AM, Chan JA, Dillon JS, Heaney AP, Kunz PL, O'Dorisio TM, Salem R, Segelov E, Howe JR, Pommier RF, Brendtro K, Bashir MA, Singh S, Soulen MC, Tang L, Zacks JS, Yao JC, Bergsland EK.

Pancreas. 2017 Jul;46(6):707-714. doi: 10.1097/MPA.0000000000000850. Review.

23.

Reliability and validity of an agility-like incremental exercise test with multidirectional change-of-direction movements in response to a visual stimulus.

Born DP, Kunz P, Sperlich B.

Physiol Rep. 2017 May;5(9). pii: e13275. doi: 10.14814/phy2.13275. Epub 2017 May 14.

24.

Understanding Neuroendocrine Tumors-A NET Gain.

Kunz PL.

JAMA Oncol. 2017 Oct 1;3(10):1343-1344. doi: 10.1001/jamaoncol.2017.0575. No abstract available.

PMID:
28448658
25.

Multi-isotope SPECT imaging of the 225Ac decay chain: feasibility studies.

Robertson AKH, Ramogida CF, Rodríguez-Rodríguez C, Blinder S, Kunz P, Sossi V, Schaffer P.

Phys Med Biol. 2017 Jun 7;62(11):4406-4420. doi: 10.1088/1361-6560/aa6a99. Epub 2017 Mar 31.

PMID:
28362640
26.

Cytotoxicity and molecular effects of biocidal disinfectants (quaternary ammonia, glutaraldehyde, poly(hexamethylene biguanide) hydrochloride PHMB) and their mixtures in vitro and in zebrafish eleuthero-embryos.

Christen V, Faltermann S, Brun NR, Kunz PY, Fent K.

Sci Total Environ. 2017 May 15;586:1204-1218. doi: 10.1016/j.scitotenv.2017.02.114. Epub 2017 Feb 21.

PMID:
28236482
27.

Development of a preclinical 211Rn/211At generator system for targeted alpha therapy research with 211At.

Crawford JR, Yang H, Kunz P, Wilbur DS, Schaffer P, Ruth TJ.

Nucl Med Biol. 2017 May;48:31-35. doi: 10.1016/j.nucmedbio.2017.01.011. Epub 2017 Jan 29.

PMID:
28193502
28.

211Rn/211At and 209At production with intense mass separated Fr ion beams for preclinical 211At-based α-therapy research.

Crawford JR, Kunz P, Yang H, Schaffer P, Ruth TJ.

Appl Radiat Isot. 2017 Apr;122:222-228. doi: 10.1016/j.apradiso.2017.01.035. Epub 2017 Jan 27.

PMID:
28189025
29.

Nonlinear polarization spectroscopy of a Rydberg state for laser stabilization.

Meyer DH, Kunz PD, Solmeyer N.

Appl Opt. 2017 Jan 20;56(3):B92-B96. doi: 10.1364/AO.56.000B92.

PMID:
28157870
30.

5 kHz Transcranial Alternating Current Stimulation: Lack of Cortical Excitability Changes When Grouped in a Theta Burst Pattern.

Kunz P, Antal A, Hewitt M, Neef A, Opitz A, Paulus W.

Front Hum Neurosci. 2017 Jan 10;10:683. doi: 10.3389/fnhum.2016.00683. eCollection 2016.

31.

Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors.

Strosberg J, El-Haddad G, Wolin E, Hendifar A, Yao J, Chasen B, Mittra E, Kunz PL, Kulke MH, Jacene H, Bushnell D, O'Dorisio TM, Baum RP, Kulkarni HR, Caplin M, Lebtahi R, Hobday T, Delpassand E, Van Cutsem E, Benson A, Srirajaskanthan R, Pavel M, Mora J, Berlin J, Grande E, Reed N, Seregni E, Öberg K, Lopera Sierra M, Santoro P, Thevenet T, Erion JL, Ruszniewski P, Kwekkeboom D, Krenning E; NETTER-1 Trial Investigators.

N Engl J Med. 2017 Jan 12;376(2):125-135. doi: 10.1056/NEJMoa1607427.

32.

Telotristat Ethyl, a Tryptophan Hydroxylase Inhibitor for the Treatment of Carcinoid Syndrome.

Kulke MH, Hörsch D, Caplin ME, Anthony LB, Bergsland E, Öberg K, Welin S, Warner RR, Lombard-Bohas C, Kunz PL, Grande E, Valle JW, Fleming D, Lapuerta P, Banks P, Jackson S, Zambrowicz B, Sands AT, Pavel M.

J Clin Oncol. 2017 Jan;35(1):14-23. Epub 2016 Oct 28.

PMID:
27918724
33.

Aggregation-induced changes in the chemical exchange saturation transfer (CEST) signals of proteins.

Goerke S, Milde KS, Bukowiecki R, Kunz P, Klika KD, Wiglenda T, Mogk A, Wanker EE, Bukau B, Ladd ME, Bachert P, Zaiss M.

NMR Biomed. 2017 Jan;30(1). doi: 10.1002/nbm.3665. Epub 2016 Nov 11.

PMID:
27859838
34.

Effect-based tools for monitoring estrogenic mixtures: Evaluation of five in vitro bioassays.

Kunz PY, Simon E, Creusot N, Jayasinghe BS, Kienle C, Maletz S, Schifferli A, Schönlau C, Aït-Aïssa S, Denslow ND, Hollert H, Werner I, Vermeirssen ELM.

Water Res. 2017 Mar 1;110:378-388. doi: 10.1016/j.watres.2016.10.062. Epub 2016 Oct 24.

PMID:
27836174
35.

CO-releasing molecule (CORM) conjugate systems.

Kautz AC, Kunz PC, Janiak C.

Dalton Trans. 2016 Nov 15;45(45):18045-18063.

PMID:
27808304
36.

Atom-at-a-time laser resonance ionization spectroscopy of nobelium.

Laatiaoui M, Lauth W, Backe H, Block M, Ackermann D, Cheal B, Chhetri P, Düllmann CE, van Duppen P, Even J, Ferrer R, Giacoppo F, Götz S, Heßberger FP, Huyse M, Kaleja O, Khuyagbaatar J, Kunz P, Lautenschläger F, Mistry AK, Raeder S, Ramirez EM, Walther T, Wraith C, Yakushev A.

Nature. 2016 Oct 27;538(7626):495-498. doi: 10.1038/nature19345. Epub 2016 Sep 28.

PMID:
27680707
37.

Oxaliplatin-Fluoropyrimidine Chemotherapy Plus Bevacizumab in Advanced Neuroendocrine Tumors: An Analysis of 2 Phase II Trials.

Kunz PL, Balise RR, Fehrenbacher L, Pan M, Venook AP, Fisher GA, Tempero MA, Ko AH, Korn WM, Hwang J, Bergsland EK.

Pancreas. 2016 Nov;45(10):1394-1400.

PMID:
27171514
38.

Dynamic contrast-enhanced ultrasound and elastography assess deltoid muscle integrity after reverse shoulder arthroplasty.

Fischer C, Krammer D, Hug A, Weber MA, Kauczor HU, Krix M, Bruckner T, Kunz P, Schmidmaier G, Zeifang F.

J Shoulder Elbow Surg. 2017 Jan;26(1):108-117. doi: 10.1016/j.jse.2016.04.012. Epub 2016 Jun 30.

PMID:
27374234
39.

Dynamic contrast-enhanced ultrasound (CEUS) after open and minimally invasive locked plating of proximal humerus fractures.

Fischer C, Frank M, Kunz P, Tanner M, Weber MA, Moghaddam A, Schmidmaier G, Hug A.

Injury. 2016 Aug;47(8):1725-31. doi: 10.1016/j.injury.2016.05.005. Epub 2016 May 14.

PMID:
27242329
40.

Neuroendocrine tumors of the pancreas: Degree of cystic component predicts prognosis.

Cloyd JM, Kopecky KE, Norton JA, Kunz PL, Fisher GA, Visser BC, Dua MM, Park WG, Poultsides GA.

Surgery. 2016 Sep;160(3):708-13. doi: 10.1016/j.surg.2016.04.005. Epub 2016 May 20.

PMID:
27216830
41.

Laboratory and field scale bioremediation of hexachlorocyclohexane (HCH) contaminated soils by means of bioaugmentation and biostimulation.

Garg N, Lata P, Jit S, Sangwan N, Singh AK, Dwivedi V, Niharika N, Kaur J, Saxena A, Dua A, Nayyar N, Kohli P, Geueke B, Kunz P, Rentsch D, Holliger C, Kohler HP, Lal R.

Biodegradation. 2016 Jun;27(2-3):179-93. doi: 10.1007/s10532-016-9765-6. Epub 2016 May 3.

PMID:
27142265
42.

Maternal Loss of Ube3a Impairs Experience-Driven Dendritic Spine Maintenance in the Developing Visual Cortex.

Kim H, Kunz PA, Mooney R, Philpot BD, Smith SL.

J Neurosci. 2016 Apr 27;36(17):4888-94. doi: 10.1523/JNEUROSCI.4204-15.2016.

43.

Synthesis of oxime-based CO-releasing molecules, CORMs and their immobilization on maghemite nanoparticles for magnetic-field induced CO release.

Meyer H, Brenner M, Höfert SP, Knedel TO, Kunz PC, Schmidt AM, Hamacher A, Kassack MU, Janiak C.

Dalton Trans. 2016 May 4;45(18):7605-15. doi: 10.1039/c5dt04888e.

PMID:
27048982
44.

A Multi-institutional Analysis of Duodenal Neuroendocrine Tumors: Tumor Biology Rather than Extent of Resection Dictates Prognosis.

Margonis GA, Samaha M, Kim Y, Postlewait LM, Kunz P, Maithel S, Tran T, Berger N, Gamblin TC, Mullen MG, Bauer TW, Pawlik TM.

J Gastrointest Surg. 2016 Jun;20(6):1098-105. doi: 10.1007/s11605-016-3135-x. Epub 2016 Mar 23.

PMID:
27008594
45.

Elevated ratio of MMP2/MMP9 activity is associated with poor response to chemotherapy in osteosarcoma.

Kunz P, Sähr H, Lehner B, Fischer C, Seebach E, Fellenberg J.

BMC Cancer. 2016 Mar 15;16:223. doi: 10.1186/s12885-016-2266-5.

46.

DNA-repair defects in pancreatic neuroendocrine tumors and potential clinical applications.

Liu IH, Ford JM, Kunz PL.

Cancer Treat Rev. 2016 Mar;44:1-9. doi: 10.1016/j.ctrv.2015.11.006. Epub 2015 Dec 24. Review.

PMID:
26924193
47.

Restoration of miR-127-3p and miR-376a-3p counteracts the neoplastic phenotype of giant cell tumor of bone derived stromal cells by targeting COA1, GLE1 and PDIA6.

Fellenberg J, Sähr H, Kunz P, Zhao Z, Liu L, Tichy D, Herr I.

Cancer Lett. 2016 Feb 1;371(1):134-41. doi: 10.1016/j.canlet.2015.10.039. Epub 2015 Nov 30.

PMID:
26655997
48.

Role of Somatostatin Analogues in the Treatment of Neuroendocrine Tumors.

Narayanan S, Kunz PL.

Hematol Oncol Clin North Am. 2016 Feb;30(1):163-77. doi: 10.1016/j.hoc.2015.09.008. Review.

PMID:
26614375
49.

Stabilizing Alginate Confinement and Polymer Coating of CO-Releasing Molecules Supported on Iron Oxide Nanoparticles To Trigger the CO Release by Magnetic Heating.

Meyer H, Winkler F, Kunz P, Schmidt AM, Hamacher A, Kassack MU, Janiak C.

Inorg Chem. 2015 Dec 7;54(23):11236-46. doi: 10.1021/acs.inorgchem.5b01675. Epub 2015 Nov 23.

PMID:
26595858
50.

New and Emerging Treatment Options for Gastroenteropancreatic Neuroendocrine Tumors.

Phan AT, Kunz PL, Reidy-Lagunes DL.

Clin Adv Hematol Oncol. 2015 May;13(5 Suppl 5):1-18; quiz 1 p following 18.

PMID:
26430956

Supplemental Content

Support Center